Clinical Trials

Showing trials with last updates posted in 2026.

NCT03493178 | ACTIVE_NOT_RECRUITING | EARLY_PHASE1
60 participants

Glutathione in Mild Cognitive Impairment

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2018-04-19
Completion:
2025-05-30
Conditions
  • Mild Cognitive Impairment
Interventions
  • DIETARY_SUPPLEMENT
No Results Yet
NCT03383575 | RECRUITING | PHASE2
63 participants

Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2018-01-17
Completion:
2027-02-28
Conditions
  • Acute Myeloid Leukemia
  • Blasts 20-30 Percent of Bone Marrow Nucleated Cells
  • Chronic Myelomonocytic Leukemia
  • IDH2 Gene Mutation
  • Myelodysplastic Syndrome With Excess Blasts
  • Recurrent High Risk Myelodysplastic Syndrome
  • Refractory High Risk Myelodysplastic Syndrome
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT03380026 | COMPLETED | PHASE2
28 participants

Mechlorethamine Induced Contact Dermatitis Avoidance Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2017-12-13
Completion:
2020-08-03
Conditions
  • Cutaneous T-cell Lymphoma
  • Cutaneous T-cell Lymphoma Stage I
  • Mycosis Fungoides
  • Folliculotropic Mycosis Fungoides
  • Granulomatous Slack Skin
  • Syringotropic Mycosis Fungoides
  • Mycosis Fungoides Variant
  • Transformed Mycosis Fungoides
Interventions
  • DRUG
NCT03340506 | RECRUITING | PHASE4
100 participants

Dabrafenib and/or Trametinib Rollover Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2018-01-26
Completion:
2032-12-28
Conditions
  • Melanoma
  • Non Small Cell Lung Cancer
  • Solid Tumor
  • Rare Cancers
  • High Grade Glioma
Interventions
  • DRUG
No Results Yet
NCT03226808 | COMPLETED | NA
245 participants

Vivacit-E Post-market Follow-up Study

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2013-10-01
Completion:
2026-04-14
Conditions
  • Osteoarthritis
  • Avascular Necrosis of Bone of Hip
  • Post-traumatic; Arthrosis
  • Congenital Hip Dysplasia
Interventions
  • DEVICE
No Results Yet
NCT02808858 | RECRUITING
10000 participants

Italian Network MDS Registry

Study Type:
OBSERVATIONAL
Last Updated:
2026-09-04
Start Date:
2013-09-30
Completion:
2016-06-30
Conditions
  • Myelodysplastic-Myeloproliferative Diseases
No Results Yet
NCT02532452 | RECRUITING | PHASE2
1000 participants

Third Party Viral Specific T-cells (VSTs)

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2015-09-02
Completion:
2028-12-31
Conditions
  • Viral Infection
  • Viral Reactivation
  • Infection in an Immunocompromised Host
Interventions
  • BIOLOGICAL
No Results Yet
NCT02208375 | ACTIVE_NOT_RECRUITING | PHASE1
159 participants

mTORC1/2 Inhibitor AZD2014 or the Oral AKT Inhibitor AZD5363 for Recurrent Endometrial and Ovarian

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2014-11-11
Completion:
2028-06-30
Conditions
  • BRCA1 Mutation Carrier
  • BRCA2 Mutation Carrier
  • Endometrial Adenocarcinoma
  • Estrogen Receptor Negative
  • HER2/Neu Negative
  • High Grade Ovarian Serous Adenocarcinoma
  • Progesterone Receptor Negative
  • Recurrent Breast Carcinoma
  • Recurrent Fallopian Tube Carcinoma
  • Recurrent Ovarian Carcinoma
  • Recurrent Primary Peritoneal Carcinoma
  • Recurrent Uterine Corpus Carcinoma
  • Stage III Uterine Corpus Cancer AJCC v7
  • Stage IV Breast Cancer AJCC v6 and v7
  • Stage IV Uterine Corpus Cancer AJCC v7
  • Triple-Negative Breast Carcinoma
Interventions
  • DRUG
  • OTHER
No Results Yet
NCT02048332 | RECRUITING | PHASE1/PHASE2
1000 participants

Donor-Derived Viral Specific T-cells (VSTs)

Study Type:
INTERVENTIONAL
Last Updated:
2026-09-04
Start Date:
2014-02-05
Completion:
2027-01-31
Conditions
  • Allogeneic Stem Cell Transplant
  • Viral Infection
  • Viral Reactivation
Interventions
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page